Category: Antibodies

In a significant move within the biopharma sector, Merck & Co. has forged an R&D collaboration with the antibody discovery startup Infinimmune. This

The exploration of disease and its origins has long been dominated by traditional paradigms, particularly the germ theory established by Louis Pasteur.

The Antibody Drug Conjugates (ADCs) market is poised for substantial growth in the coming years. With a projected increase from USD 8.02 billion in 2026

Viridian Therapeutics recently faced a challenging moment as its investigational antibody for thyroid eye disease, elegrobart, reported results that both

In the dynamic world of biotechnology, the demand for reliable, high quality antibodies is paramount. Custom polyclonal antibody production offers

In the evolving landscape of biotechnology, the development of antibody derivatives has emerged as a focal point for innovation and efficiency.

The field of virology continues to innovate, particularly in the study of bunyaviruses. Recent advances in understanding the genetic and structural

The landscape of oncology is rapidly evolving, and at the forefront of this transformation are antibody drug conjugates (ADCs). These innovative therapies

In a significant advancement in the biotech landscape, Infinimmune has announced a strategic collaboration with Merck, a deal that could reach an

The collaboration between Boehringer Ingelheim and EMFRET Analytics marks a significant advancement in the development of EMA601, a promising GPVI

Sartorius has unveiled a cutting edge genetically engineered CHO host cell line, promising significant advancements in productivity and efficiency for

Continuous biopharmaceutical manufacturing is on a trajectory for significant growth, projected to expand by 17% by 2033. This increase stems from its

Samsung Biologics is at the forefront of enhancing the late stage discovery process for biologics development. By leveraging advanced proprietary

The biopharma landscape continues to evolve rapidly, with significant advancements and approvals shaping the future of treatment options. In particular,

The biosimilars market is experiencing a transformative phase that holds promise for both healthcare providers and patients. As regulatory frameworks

Faron Pharmaceuticals is embarking on a promising journey in collaboration with City of Hope, a leading cancer research organization. Together, they are

JYNNEOS, a third generation smallpox vaccine, plays a crucial role in controlling monkeypox virus (MPXV) outbreaks, yet the longevity of its protective

In the dynamic realm of biotherapeutics, particularly monoclonal antibodies (mAbs) and antibody drug conjugates (ADCs), the success of these therapies

Selecting the optimal ELISA assay kit can significantly impact the success of experiments designed to measure proteins, cytokines, or biomarkers. With a

The evolving landscape of monoclonal antibody research promises groundbreaking advancements in medical biotechnology. This dynamic one day symposium

Kyowa Kirin has made the significant decision to halt all ongoing clinical trials for rocatinlimab, an anti OX40 monoclonal antibody being investigated